Insulin Lispro

Insulin lispro, the active ingredient in Insulin Lispro, is a rapid‑acting insulin analog presented as a sterile solution for subcutaneous or intravenous use. It lowers blood glucose by mimicking natural insulin shortly after injection and is used in patients with type 1 or type 2 diabetes mellitus.

GNH USA supplies Insulin Lispro as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our distribution network ensures product integrity and timely delivery across EU and global markets.

Insulin lispro is a rapid‑acting insulin analog used to manage blood glucose in diabetes mellitus and related insulin delivery systems.

- Type 1 diabetes mellitus: provides prompt post‑prandial glucose control. - Type 2 diabetes mellitus: supplies rapid insulin coverage for meals. - Insulin pump therapy: serves as the rapid‑acting insulin in continuous subcutaneous insulin infusion devices.

Insulin lispro may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Hypoglycemia: low blood sugar episodes. - Injection site reactions: redness, swelling, or itching. - Weight gain: increase in body weight with chronic use. - Lipodystrophy: localized fat tissue changes at injection sites. - Localized allergic reactions: mild rash or urticaria.

Serious or Rare Side Effects: - Severe hypoglycemia: neurological impairment or loss of consciousness. - Anaphylaxis: life‑threatening systemic allergic reaction. - Hypokalemia: low potassium levels. - Edema: fluid accumulation, especially in lower extremities. - Serum sickness‑like reaction: fever, arthralgia, and rash. - Severe allergic dermatitis: extensive skin involvement.

When using insulin lispro, several safety considerations should be observed.

- Blood glucose monitoring: check levels frequently to avoid hypoglycemia. - Dose adjustment during illness: reduce or increase dose based on carbohydrate intake and activity. - Avoid use in existing hypoglycemia: do not administer if blood glucose is already low. - Renal impairment: use caution and consider dose modification. - Pregnancy and lactation: discuss risks with a healthcare professional. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Insulin lispro can interact with other medicines, altering its effectiveness or safety.

Major Interactions (Avoid): - Beta‑blockers: may mask hypoglycemia symptoms. - Alcohol: can potentiate insulin’s glucose‑lowering effect.

Moderate Interactions (Monitor Closely): - MAO inhibitors: may enhance insulin action. - Corticosteroids: can increase blood glucose, requiring dose adjustment. - Thiazide diuretics: may raise blood glucose levels. - ACE inhibitors: may potentiate hypoglycemia, especially in renal impairment.